Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04295642 | A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease | PHASE1 | COMPLETED | 24 | — | — | Jan 1, 2020 | Jul 1, 2021 | Aug 30, 2021 | - | — |
| Name | Type | Description |
|---|---|---|
| CVL-751 | DRUG | Oral tablet |